Log in
Enquire now
Good Therapeutics

Good Therapeutics

Good Therapeutics is a better protein therapeutics founded in 2016 by John Mulligan.

OverviewStructured DataIssuesContributors

Contents

goodtherapeutics.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Pharmaceutical industry
Pharmaceutical industry
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Biopharmaceutical
Biopharmaceutical
Biomedical engineering
Biomedical engineering
Engineering
Engineering
Location
Seattle
Seattle
0
B2X
B2B
B2B
0
CEO
‌
John Mulligan (entrepreneur)
0
Founder
‌
John Mulligan (entrepreneur)
0
Pitchbook URL
pitchbook.com/profiles...179654-77
Number of Employees (Ranges)
11 – 500
Email Address
info@goodtherapeutics.com0
Phone Number
+120688884850
Full Address
1616 Eastlake Avenue East Suite 400 Seattle, WA 981020
Investors
RiverVest Venture Partners
RiverVest Venture Partners
0
Digitalis Ventures
Digitalis Ventures
0
Codon Capital
Codon Capital
0
Roche Venture Fund
Roche Venture Fund
0
Founded Date
2016
0
Country
United States
United States
0

Other attributes

Company Operating Status
Active
Invested in
Roche Venture Fund
Roche Venture Fund
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Good Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.